Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nicotine and brain disorders.

S Mihailescu1, R Drucker-Colín

  • 1Departamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México, México.

Acta Pharmacologica Sinica
|March 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retracted: Hypocretin (orexin) cell transplantation diminishes narcoleptic-like sleep behavior in rats.

CNS & neurological disorders drug targets·2012
Same author

Neuroprotective effects of extremely low-frequency electromagnetic fields on a Huntington's disease rat model: effects on neurotrophic factors and neuronal density.

Neuroscience·2012
Same author

Fetal substantia nigra and adrenal medullary grafts placed contralateral to the nigrostriatal lesion side induce a decrease in turning behavior but not in dopamine receptor density.

Restorative neurology and neuroscience·2011
Same author

Aspects of the narcolepsy-cataplexy syndrome in O/E3-null mutant mice.

Neuroscience·2011
Same author

Dopamine D(2)-class receptor supersensitivity as reflected in Ca2+ current modulation in neostriatal neurons.

Neuroscience·2009
Same author

The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain.

Neuroscience·2008
Same journal

Molecular mechanisms for sustaining cancer stem cells characteristics and targeted therapeutic strategies.

Acta pharmacologica Sinica·2026
Same journal

Targeting BCL9/BCL9L enhances CD4<sup>+</sup> T cell-mediated Th1 antitumor immunity through activation of STAT1/STAT4 signaling.

Acta pharmacologica Sinica·2026
Same journal

TGF-β2 signaling promotes cardiac fibrosis in arrhythmogenic right ventricular cardiomyopathy mediated by DSC2 deficiency.

Acta pharmacologica Sinica·2026
Same journal

Correction: Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy.

Acta pharmacologica Sinica·2026
Same journal

Endothelial PARP1 orchestrates endothelial-to-mesenchymal transition via the PARylation of FHL2 in ischaemic heart failure.

Acta pharmacologica Sinica·2026
Same journal

Correction: Myeloid-derived growth factor suppresses VSMC dedifferentiation and attenuates postinjury neointimal formation in rats by activating S1PR2 and its downstream signaling.

Acta pharmacologica Sinica·2026
See all related articles

Brain nicotinic acetylcholine receptors are key in cognition and brain disorders. Nicotine shows therapeutic potential for conditions like Alzheimer's and Parkinson's diseases.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Brain nicotinic acetylcholine receptors (nAChRs) have been extensively studied electrophysiologically and pharmacologically.
  • These receptors are implicated in cognitive functions and the pathology of neurological and psychiatric disorders.

Purpose of the Study:

  • To review recent findings on the structure and function of neuronal nicotinic receptors.
  • To explore their role in the pathogenesis of brain disorders.
  • To summarize the therapeutic and prophylactic effects of nicotine.

Main Methods:

  • Literature review of recent electrophysiological and pharmacological studies.
  • Analysis of clinical data on nicotine's effects in brain disorders.

Main Results:

Related Experiment Videos

  • Neuronal nAChRs are crucial for memory and cognition.
  • Dysfunction of nAChRs is linked to Parkinson's, Alzheimer's, schizophrenia, and other disorders.
  • Nicotine demonstrates beneficial effects as a therapeutic agent in these conditions.

Conclusions:

  • Neuronal nAChRs are significant targets for understanding and treating brain disorders.
  • Nicotine's properties warrant further investigation for therapeutic applications in neurological and psychiatric diseases.